Key result
Relocation of a pacemaker to the abdomen using an epicardial lead allowed for safe delivery of 62 Gy of radiotherapy for overlapping lung cancer without pacemaker malfunction.
Why the study?
When lung cancer overlaps a pacemaker site and radiation is required, the pacemaker must be relocated to avoid direct radiation exposure.
Does pacemaker relocation prevent radiation-induced device malfunction in patients requiring radiotherapy for tumors overlapping the original pacemaker site?
Case Report (n=1)
Does pacemaker relocation prevent radiation-induced device malfunction in patients requiring radiotherapy for tumors overlapping the original pacemaker site?
Pacemaker relocation using an epicardial lead and abdominal generator is a viable option to avoid direct radiation exposure in patients requiring radiotherapy for tumors overlapping the device.
Answers are grounded in this paper and cite their sources.
Pacemaker relocation to abdomen enabled radiotherapy in this case; leaves open generalizability and safety in similar patients.
We experienced a patient after pacemaker (PM) implantation who had lung cancer of the left upper lobe that developed just behind the PM. The patient was an 81-year-old man with many complications. Radiation was the only treatment option. The PM had to be moved to another place to avoid direct radiation exposure to it. An epicardial pacing lead was implanted on the right ventricular epicardium, and the new generator was implanted in the abdomen. The patient was treated with a total of 62 Gy of radiotherapy for lung cancer, achieving a temporary shrinkage of the tumor. During the radiotherapy period, the PM functioned well without harmful events. When radiation therapy is needed in cases where the tumor overlaps the PM, relocation surgery using an epicardial pacing lead may be a useful option.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2023) conducted a case report in Lung cancer overlapping with a pacemaker (n=1). Pacemaker relocation to the abdomen using an epicardial pacing lead was evaluated on Pacemaker function and tumor response during and after radiotherapy. Relocation of a pacemaker to the abdomen using an epicardial lead allowed for safe delivery of 62 Gy of radiotherapy for overlapping lung cancer without pacemaker malfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: